TEVA Pharmaceutical Industries Limited
| TEVA Pharmaceutical Industries Limited contact information is shown below | |
| Owner: | TEVA PHARMACEUTICAL INDUSTRIES LIMITED |
|---|---|
| Owner Address: | 124 Dvora HaNevi'a St. Tel Aviv 6944020 Israel |
| Owner Web Site | |
| Owner Phone | |
| Owner Toll Free | |
| Owner Fax |
Brands Owned byTEVA Pharmaceutical Industries Limited
| Brand: |
ACCESS ASSIST |
|---|---|
| Description: | Educational services relating to migraine treatment and self-infusion of pharmaceuticals;Financial services relating to reimbursement of medical insurance payments;Providing medical services for the treatment of migraines; |
| Category: | EDUCATIONAL SERVICES RELATING MIGRAINE |
| Brand: |
ALLOSTRUCT |
|---|---|
| Description: | Pharmaceutical preparations for the treatment of cardiovascular diseases; |
| Category: | PHARMACEUTICAL PREPARATIONS TREATMENT |
| Brand: |
ALLOSTRUX |
|---|---|
| Description: | Pharmaceutical preparations for the treatment of cardiovascular diseases; |
| Category: | PHARMACEUTICAL PREPARATIONS TREATMENT |
| Brand: |
ATTENUFERON |
|---|---|
| Description: | Pharmaceutical preparations for the treatment of cancer and autoimmune diseases; |
| Category: | PHARMACEUTICAL PREPARATIONS TREATMENT |
| Brand: |
ATTENUFERON |
|---|---|
| Description: | Pharmaceutical preparations for the treatment of cancer and autoimmune diseases; |
| Category: | PHARMACEUTICAL PREPARATIONS TREATMENT |
| Brand: |
ATTENUKINE |
|---|---|
| Description: | Pharmaceutical preparations for the treatment of cancer and autoimmune diseases; |
| Category: | PHARMACEUTICAL PREPARATIONS TREATMENT |
| Brand: |
BIRIDA |
|---|---|
| Description: | antiretroviral drug for the treatment of HIV-1 infection; |
| Category: | ANTIRETROVIRAL DRUG TREATMENT |
| Brand: |
CENMIRA |
|---|---|
| Description: | Pharmaceutical preparations for the treatment of migraines; |
| Category: | PHARMACEUTICAL PREPARATIONS TREATMENT |
| Brand: |
CENMIRA |
|---|---|
| Description: | Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations for the treatment of neurological disorders; |
| Category: | PHARMACEUTICAL PREPARATIONS PREVENTION |
| Brand: |
CINQAIR |
|---|---|
| Description: | The mark consists of the word CINQAIR in dark blue capital letters. There is a design of squares with round edges above the letters NQAIR that stretch into a triangular shape as they move away from the word. The squares are light green, dark green, light blue, and dark blue.;Pharmaceutical preparations for the treatment of inflammatory disorders;The color(s) light green, dark green, light blue, and dark blue is/are claimed as a feature of the mark.; |
| Category: |